Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Carna Biosciences

Market Cap: JP¥6.1b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Chugai Pharmaceutical

Market Cap: JP¥12.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

CellSource

Market Cap: JP¥13.6b

Engages in the regenerative medicine-related businesses in Japan.

TMS

Market Cap: JP¥6.7b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Kissei Pharmaceutical

Market Cap: JP¥175.5b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Ribomic

Market Cap: JP¥4.0b

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.

CanBas

Market Cap: JP¥18.8b

A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.

Daiichi Sankyo Company

Market Cap: JP¥6.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Solasia Pharma K.K

Market Cap: JP¥6.8b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

Takara Bio

Market Cap: JP¥93.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Kringle Pharma

Market Cap: JP¥6.2b

Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.

DNA Chip Research

Market Cap: JP¥7.3b

Develops DNA microarrays in Japan.

FunPep

Market Cap: JP¥3.9b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

Noile-Immune Biotech

Market Cap: JP¥7.4b

Researches and develops CAR-T cells for cancer immunotherapies.

Nippon Shinyaku

Market Cap: JP¥238.1b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Santen Pharmaceutical

Market Cap: JP¥551.8b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Chordia Therapeutics

Market Cap: JP¥15.9b

A biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Veritas In Silico

Market Cap: JP¥4.3b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Shionogi

Market Cap: JP¥2.1t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

WDB coco

Market Cap: JP¥7.2b

Provides contract services to pharmaceutical companies in Japan.

Seikagaku

Market Cap: JP¥35.0b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

ReproCELL

Market Cap: JP¥16.8b

Provides stem cell research and drug discovery services in Japan.

Delta-Fly Pharma

Market Cap: JP¥6.2b

Develops anticancer drugs.

Tsumura

Market Cap: JP¥251.0b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Immuno-Biological Laboratories

Market Cap: JP¥4.8b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥65.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Heartseed

Market Cap: JP¥64.0b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

SanBio

Market Cap: JP¥263.6b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

OncoTherapy Science

Market Cap: JP¥6.3b

Engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.

StemRIM

Market Cap: JP¥19.9b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

Renascience

Market Cap: JP¥21.7b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

Modalis Therapeutics

Market Cap: JP¥5.8b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

MedRx

Market Cap: JP¥2.9b

A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.

Perseus Proteomics

Market Cap: JP¥6.7b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

Mochida Pharmaceutical

Market Cap: JP¥104.5b

Manufactures and sells pharmaceuticals and healthcare products in Japan.